VIVOBIOT.NS

Healthcare Biotechnology

Vivo Bio Tech Limited

₹14.93

+0.42 +2.89% today

Price History

Not enough data

Key Stats

Market Cap

331.31M

Avg Volume

28,789

EPS

-₹1.43

52W High

₹20.44

52W Low

₹12.80

Div. Yield

0.0%

Valuation

P/B Ratio

0.33

P/S Ratio

0.60

EV/EBITDA

4.82

EV/Revenue

1.84

Margins

Gross Margin 84.6%

Operating Margin 10.7%

Net Margin (5.2%)

EBITDA Margin 38.2%

Growth & Returns

Revenue Growth (YoY)

14.1%

Earnings Growth (YoY)

(89.2%)

Earnings Growth (QoQ)

(86.0%)

Liquidity & Leverage

Debt / Equity

0.72

Total Cash

14.36M

Total Debt

673.80M

About

Vivo Bio Tech Limited provides drug development and discovery services to pharmaceutical and biotech companies worldwide. The company offers services in the areas of in vivo and in vitro toxicity studies, pharmacological investigations, pharmacokinetic and toxic kinetic studies, genotoxicity screening, analytical, and other services. It also supplies specific pathogen free lab animals; breeders and distributes rodent models; and designs and develops of syngeneic / xenograft models for evaluation of anti-cancer agents evaluation, as well as offers custom rodent models, stem cell products, and lab animal diets. In addition, the company provides regulatory and non-regulatory IND preclinical development services; and screening and evaluating molecules for various pharmacological properties. The company was formerly known as Sunshine Factors & Exports Limited and changed its name to Vivo Bio Tech Limited in September 2002. Vivo Bio Tech Limited was incorporated in 1987 and is based in Hyderabad, India.